236 related articles for article (PubMed ID: 35953673)
21. Compact RNA editors with small Cas13 proteins.
Kannan S; Altae-Tran H; Jin X; Madigan VJ; Oshiro R; Makarova KS; Koonin EV; Zhang F
Nat Biotechnol; 2022 Feb; 40(2):194-197. PubMed ID: 34462587
[TBL] [Abstract][Full Text] [Related]
22. Deep learning and CRISPR-Cas13d ortholog discovery for optimized RNA targeting.
Wei J; Lotfy P; Faizi K; Baungaard S; Gibson E; Wang E; Slabodkin H; Kinnaman E; Chandrasekaran S; Kitano H; Durrant MG; Duffy CV; Pawluk A; Hsu PD; Konermann S
Cell Syst; 2023 Dec; 14(12):1087-1102.e13. PubMed ID: 38091991
[TBL] [Abstract][Full Text] [Related]
23. Structural basis for the activation of a compact CRISPR-Cas13 nuclease.
Deng X; Osikpa E; Yang J; Oladeji SJ; Smith J; Gao X; Gao Y
Nat Commun; 2023 Sep; 14(1):5845. PubMed ID: 37730702
[TBL] [Abstract][Full Text] [Related]
24. Rapidly Characterizing CRISPR-Cas13 Nucleases Using Cell-Free Transcription-Translation Systems.
Wandera KG; Beisel CL
Methods Mol Biol; 2022; 2404():135-153. PubMed ID: 34694607
[TBL] [Abstract][Full Text] [Related]
25. Potential Use of CRISPR/Cas13 Machinery in Understanding Virus-Host Interaction.
Bayoumi M; Munir M
Front Microbiol; 2021; 12():743580. PubMed ID: 34899631
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-Cas13 Precision Transcriptome Engineering in Cancer.
Granados-Riveron JT; Aquino-Jarquin G
Cancer Res; 2018 Aug; 78(15):4107-4113. PubMed ID: 30021724
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-Cas13 technology portfolio and alliance with other genetic tools.
Wu S; Tian P; Tan T
Biotechnol Adv; 2022 Dec; 61():108047. PubMed ID: 36208845
[TBL] [Abstract][Full Text] [Related]
28. The effects of length and sequence of gRNA on Cas13b and Cas13d activity in vitro and in vivo.
Liu Y; Jing P; Zhou Y; Zhang J; Shi J; Zhang M; Yang H; Fei J
Biotechnol J; 2023 Sep; 18(9):e2300002. PubMed ID: 37148478
[TBL] [Abstract][Full Text] [Related]
29. AAV-CRISPR-Cas13 eliminates human enterovirus and prevents death of infected mice.
Keng CT; Yogarajah T; Lee RCH; Muhammad IBH; Chia BS; Vasandani SR; Lim DS; Guo K; Wong YH; Mok CK; Chu JJH; Chew WL
EBioMedicine; 2023 Jul; 93():104682. PubMed ID: 37390772
[TBL] [Abstract][Full Text] [Related]
30. Programmable RNA base editing with photoactivatable CRISPR-Cas13.
Yu J; Shin J; Yu J; Kim J; Yu D; Heo WD
Nat Commun; 2024 Jan; 15(1):673. PubMed ID: 38253589
[TBL] [Abstract][Full Text] [Related]
31. A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila.
Huynh N; Depner N; Larson R; King-Jones K
Genome Biol; 2020 Nov; 21(1):279. PubMed ID: 33203452
[TBL] [Abstract][Full Text] [Related]
32. Development and application of sensitive, specific, and rapid CRISPR-Cas13-based diagnosis.
Shihong Gao D; Zhu X; Lu B
J Med Virol; 2021 Jul; 93(7):4198-4204. PubMed ID: 33599292
[TBL] [Abstract][Full Text] [Related]
33. Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice.
Yan Z; Yao Y; Li L; Cai L; Zhang H; Zhang S; Xiao Q; Wang X; Zuo E; Xu C; Wu J; Yang H
Mol Ther Nucleic Acids; 2023 Sep; 33():750-761. PubMed ID: 37621413
[TBL] [Abstract][Full Text] [Related]
34. Applications of the versatile CRISPR-Cas13 RNA targeting system.
Kordyś M; Sen R; Warkocki Z
Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
[TBL] [Abstract][Full Text] [Related]
35. Efficient nanoparticle-based CRISPR-Cas13d induced mRNA disruption of an eye pigmentation gene in the white-backed planthopper, Sogatella furcifera.
Ma YF; Zhang MQ; Gong LL; Liu XZ; Long GJ; Guo H; Hull JJ; Dewer Y; He M; He P
Insect Sci; 2023 Dec; 30(6):1552-1564. PubMed ID: 37202920
[TBL] [Abstract][Full Text] [Related]
36. Programmable Inhibition and Detection of RNA Viruses Using Cas13.
Freije CA; Myhrvold C; Boehm CK; Lin AE; Welch NL; Carter A; Metsky HC; Luo CY; Abudayyeh OO; Gootenberg JS; Yozwiak NL; Zhang F; Sabeti PC
Mol Cell; 2019 Dec; 76(5):826-837.e11. PubMed ID: 31607545
[TBL] [Abstract][Full Text] [Related]
37. In silico optimization of RNA-protein interactions for CRISPR-Cas13-based antimicrobials.
Park HM; Park Y; Berani U; Bang E; Vankerschaver J; Van Messem A; De Neve W; Shim H
Biol Direct; 2022 Oct; 17(1):27. PubMed ID: 36207756
[TBL] [Abstract][Full Text] [Related]
38. A Novel Miniature CRISPR-Cas13 System for SARS-CoV-2 Diagnostics.
Mahas A; Wang Q; Marsic T; Mahfouz MM
ACS Synth Biol; 2021 Oct; 10(10):2541-2551. PubMed ID: 34546709
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cas13d-mediated efficient KDM5B mRNA knockdown in porcine somatic cells and parthenogenetic embryos.
Bi D; Yao J; Wang Y; Qin G; Zhang Y; Wang Y; Zhao J
Reproduction; 2021 Jul; 162(2):149-160. PubMed ID: 34096883
[TBL] [Abstract][Full Text] [Related]
40. Targeting of SPCSV-RNase3 via CRISPR-Cas13 confers resistance against sweet potato virus disease.
Yu Y; Pan Z; Wang X; Bian X; Wang W; Liang Q; Kou M; Ji H; Li Y; Ma D; Li Z; Sun J
Mol Plant Pathol; 2022 Jan; 23(1):104-117. PubMed ID: 34633749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
